Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE versus POTASSIUM CHLORIDE 0 15 IN SODIUM CHLORIDE 0 45.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE versus POTASSIUM CHLORIDE 0 15 IN SODIUM CHLORIDE 0 45.
MAGNESIUM SULFATE vs POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Potassium is the principal intracellular cation; it corrects hypokalemia and maintains cellular membrane potential. Sodium chloride provides sodium and chloride ions to maintain fluid balance and osmolarity.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
Intravenous infusion: Typically 10-20 mEq/h (max 40 mEq/h) with continuous ECG monitoring; rate not to exceed 1 mEq/min. Concentration: 0.15% KCl in 0.45% NaCl provides 2 mEq KCl per 100 mL. Administer via central line if concentration > 0.1%.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateTerminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Not applicable as potassium is an electrolyte; its serum half-life depends on redistribution and renal function. In normal renal function, excess exogenous potassium is eliminated within hours; terminal elimination half-life is approximately 2-4 hours in healthy individuals but prolonged in renal impairment.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Renal: >90% of administered potassium is excreted by the kidneys, primarily via distal tubular secretion in the collecting duct. Fecal: <10% eliminated in feces. Biliary: negligible.
Category C
Category A/B
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."